December 2023 update

I stopped posting updates to this blog almost one year ago. At the time, I was deeply involved in producing yet another academic paper (It’s out!) and we had just had our second child.

I still like the process of writing my ideas and sharing them with others. But the process has become too time consuming. And, sadly, the payoff in a noisy world is pretty thin.

Having some experience of the whole key-opinion-leader (KOL) process I don’t think that I’m ever going to be very successful on that path.

Decisions

Three key decisions are relevant for the current post

  1. Commission somebody to redesign this site. I need to make it more navigable, so that you the reader can access the more relevant posts on your first visit.
  2. Post considerably less frequently. Yes I will begin to write again, but the articles will only be posted after the redesign.
  3. Display a thread of some of my most relevant articles as a first contact point for the interim. (Coming next week).

About me

I am still a life-sciences and technology founder. I still prefer the technical rather than business role, although I frequently do both albeit rarely at the same time. I came very close to founding a Software-as-a-InVitro-Diagnostic (SaIVD) company in 2023, unfortunately our hopes did not come to fruition. I earn my income from advising others on Team, Architecture and Build. Mostly I get paid to solve serious problems. I also do due diligence for investors.

New hosting

I have had to move my website hosting this week. I was hosted by the computer society at National University of Ireland, Galway for many years. Their hardware is now on its last legs and the building it is hosted in has been turned into a field hospital for Covid patients. It was time to move on.

Many thanks to Compsoc at NUI Galway for the years of hosting.

Invited Speaker: Dynamics of Immune Responses

I have been invited to speak at the Dynamics of Immune Responses workshop/seminar/conference in May-June 2020. The invitation arose through my previous efforts to found a company in this space.

There is a growing awareness in the field of immunology of the potential for using mathematical techniques. The wedge-issue here is the cascade of data appearing via new cytometry techniques; large-data looks like a math issue to most people. I of course come from the other side of a spectrum – everything looks like a math issue to me – I wanted to stimulate drug development which engages with immune system dynamics by founding my company.

Continue reading “Invited Speaker: Dynamics of Immune Responses”